A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.

More than 37 million people in the United States suffer from migraines. If you’re one of them, you know they can be triggered ...

MR is associated with better treatment response than gepants in patients with migraine who previously had an inadequate response to gepants.

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

A 75% plus increase in good days/month with eptinezumab is associated with improved migraine symptoms, brain fog, and overall well-being in chronic migraine.

Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ventricular arrhythmia/cardiac arrest, an investigator reported at the 62 nd European Renal ...

Although anti-calcitonin gene-related peptides are safe and efficacious for adolescents with chronic migraine, access to ...

But many people who think they have migraines actually suffer from tension headaches, cluster headaches, or other headache types that require completely different treatment approaches to find real ...

Atogepant 60 mg once daily leads to meaningful weight loss in patients with overweight or obesity receiving preventive ...

Migraines are one of the top ten most debilitating illnesses. That is according to the World Health Organization. They are ...